Since its beginning, TransTech developed and commercialized five new, patented products.
These are the following instruments
- Pavement Temperature Sensor (PTS)
- Shoulder Wedge Maker
- Notched Wedge Joint Maker
- Pavement Quality Indicator 301 (PQI 301)
- Pavement Quality Indicator 380 (PQI 380)
- Soil Density Gauge 200 (SDG 200)
To date, these new products have met with excellent reception by commercial customers, contractors, and government agencies around the world. TransTech’s flagship product, the PQI, has a strong presence in the international market as well, with sales into more than 80 countries. The PQI is an example of TransTech’s ability of transferring technology from R&D to commercialization. This instrumentation product, coupling an advanced electronic impedance sensor with digital data analysis and processing circuitry, went from concept to commercial product in a two-year period. The original research and development project was co-sponsored by TransTech, the New York State Energy Research and Development Authority and the Transportation Research Board.
The Soil Density Gauge (SDG) was introduced to the market in August 2008 and was designed for a selected class of soils of most interest in civilian and military construction. The SDG permits a non-destructive and rapid inspection of soils. The technical approach is based on the use of electromagnetic impedance spectroscopy (EIS) to measure soil properties such as density and moisture. Adjustment of field soil conditions to laboratory calibration accomplished by entry of results of standard laboratory tests into the SDG. The original research and development project was co-sponsored by TransTech, the New York State Energy Research and Development Authority, and the U.S. Dept of Homeland Security.
While TransTech has been, and is primarily a commercial product and service-oriented business, the management team comes from the leadership of companies that strategically utilized research and development to spawn new products. Spin-offs of EIS have wide ranging applications not only in other civil infrastructure areas, but in biomedical instrumentation and various industrial manufacturing quality control uses. The most recent application of the technology is for a biomedical application in diabetes treatment. This prototype product is developed to the point of proving that the basic concept of combining EIS and EIT to determine variations in glucose levels is feasible. TransTech has spent a number of years and dollars in the development of the impedance spectroscopy and tomography platform technologies that are the basis for the non-invasive continuous glucose monitor.